Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2001
11/01/2001CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001CA2407013A1 Pharmaceutical composition promoting defecation
11/01/2001CA2406982A1 Zolpidem hemitartrate
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406839A1 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001CA2406725A1 Edg8 receptor, its preparation and use
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406532A1 Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus compri sing alkyl and aryl alanine p2 moieties
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2406073A1 A protein kinase c variant to alter memory
11/01/2001CA2405983A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001CA2405680A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001CA2405565A1 Compounds for treating fibromyalgia and chronic fatigue syndrome
11/01/2001CA2405559A1 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2405138A1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001CA2405025A1 (2-aminoethyl) oxime derivatives for the treatment of depression
11/01/2001CA2399741A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001CA2372673A1 Cyclic amidine compounds
10/2001
10/31/2001EP1149908A1 TGF-beta type receptor cDNAs and uses thereof
10/31/2001EP1149842A2 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/31/2001EP1149581A2 Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/31/2001EP1149580A1 Use of heteroaryl substituted N-(Indole-2-Carbonyl-) amides for the manufacture of a medicament for the treatment of infection
10/31/2001EP1149168A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
10/31/2001EP1149161A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert)
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149105A1 4,5-pyrazinoxindoles as protein kinase inhibitors
10/31/2001EP1149104A2 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
10/31/2001EP1149103A1 Thienylbenzoylbenzazepines as vasopressin agonists
10/31/2001EP1149101A1 4-OXO-3,5-DIHYDRO-4$i(H)-PYRIDAZINO 4,5-$i(b)]INDOLE-1-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE
10/31/2001EP1149097A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
10/31/2001EP1149096A2 Tricyclic pyridine n-oxides vasopressin agonists
10/31/2001EP1149094A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
10/31/2001EP1149093A1 4-aryloxindoles as inhibitors of jnk protein kinases
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149087A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1149080A2 Crystalline form of benzoquinoline-3-one derivative as inhibitor of 5-alpha reductase
10/31/2001EP1149079A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1149067A1 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148881A1 USE OF PYRIDAZINO 4,5-$i(b)]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
10/31/2001EP1148877A1 Methods for inhibiting bone resorption
10/31/2001EP1148876A1 Calcilytic compounds
10/31/2001EP1148874A1 Use of anticonvulsant derivatives for treating bulimia nervosa
10/31/2001EP1148873A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
10/31/2001EP1148872A1 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/31/2001EP1148783A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001EP1108428A9 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof
10/31/2001EP1044201A4 3-substituted adenines via2-thioxanthines
10/31/2001EP0991670B1 Method for fixing or separating ions, in particular of lead, using per(3,6-anhydro) cyclodextrin derivatives
10/31/2001EP0901466B1 Biphenylsulfonamide matrix metalloproteinase inhibitors
10/31/2001EP0869946B1 Phenylimidazolidines and use thereof as an antiandrogenic agent
10/31/2001EP0869806B1 A pharmaceutical composition comprising plant worms and muirapuama
10/31/2001EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/31/2001EP0811001B1 Benzothiazine dioxides as endothelin antagonists
10/31/2001EP0800524B1 6-[triazolyl[ 3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones
10/31/2001EP0787131B1 Benzenesulphonamide derivatives as bradykinine antagonists
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001EP0759760B1 Wound healing agent
10/31/2001EP0743943B1 Pyridyl imidazole derivatives and processes for the preparation thereof
10/31/2001EP0737192B1 Substituted morpholine derivatives and their use as therapeutic agents
10/31/2001DE10021256A1 Neue, photolabile Cumarinylmethylester von cyclischen Nucleotiden, Verfahren zu deren Herstellung und ihre Verwendung New photolabile coumarinylmethyl esters of cyclic nucleotides, processes for their preparation and their use
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001DE10019136A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1320039A Reduction of oxidative stress factors
10/31/2001CN1319674A Sieving method for inhibiting tumor compound and medicinal compositions containing same
10/31/2001CN1319593A Process for prpearing 11-amino-3-chlorine-6,11-dihydrogen-5,5-dioxo-6-methyl-dibenzo [c,f][1,2] thiazine and application of synthetic tianeptine
10/31/2001CN1319425A Medical preparation for stasis-eliminating and soothing sinew
10/31/2001CN1319408A Medicated liquor for treating traumatic injury
10/31/2001CN1319396A Medicinal composition
10/31/2001CN1319392A Pharmaceutical use of gorgonian acid
10/31/2001CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073991C Antilysin used reverse transcription enzyme inhibitor crystallizing technology
10/31/2001CN1073850C Desert cistanche granule
10/30/2001US6310247 7-aryl-6(Z)-heptatrienoic acid retinamides
10/30/2001US6310217 Antiinflammatory and analgesic agents
10/30/2001US6310205 Intermediates for preparing 3-substituted adenines and 3,8-di-substituted 6-aminopurine derivatives for use as phosphodiesterase inhibitors.
10/30/2001US6310203 Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands
10/30/2001US6310177 Compounds and methods for modulating tissue permeability
10/30/2001US6310094 Ready-to-use esmolol solution
10/30/2001US6310092 Treating systemic lupus, multiple sclerosis, rheumatoid arthritis, septic shock, erythema nodosum leprosy, septicemia, uveitis, adult respiratory distress syndrome or inflammatory bowel disease
10/30/2001US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors
10/30/2001US6310084 Inhibitors of metalloproteases involved in tissue degradation
10/30/2001US6310082 Benzimidazole compounds
10/30/2001US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6310075 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
10/30/2001US6310074 Substituted dimeric compounds
10/30/2001US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
10/30/2001US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
1 ... 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 ... 1564